ACE2 and COVID-19: In the case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, the scientific community extensively studied interactions between the viral spike glycoprotein and the cellular receptor angiotensin-converting enzyme 2 (ACE2) (5).